XVIVO: Softer growth in the quarter, together with significant structural progress - Redeye
Börskollen - Aktier, fonder och ekonominyheter

Börskollen

För dig med koll på börsen

Aktieanalys

XVIVO: Softer growth in the quarter, together with significant structural progress - Redeye

{newsItem.title}

As expected, Q1 is a modest quarter after an extended period of high organic growth. XVIVO continues to increase its supply capacity gradually, and XVIVO also needs to increase inventory levels throughout 2025 to satisfy demand. XVIVO continues to expect high demand for its portfolio of high-margin consumables.

Länk till analysen i sin helhet: https://www.redeye.se/research/1096862/xvivo-softer-growth-in-the-quarter-together-with-significant-structural-progress?utm_source=finwire&utm_medium=RSS

Nyheter om Xvivo Perfusion

Läses av andra just nu

Om aktien Xvivo Perfusion

Senaste nytt